Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment
about
Hallmarks of glycosylation in cancerRelationship between hypoxia and response to antiangiogenic therapy in metastatic colorectal cancerGalectin-1 expression imprints a neurovascular phenotype in proliferative retinopathies and delineates responses to anti-VEGFTiming of galectin-1 exposure differentially modulates Nipah virus entry and syncytium formation in endothelial cells.Re-wiring regulatory cell networks in immunity by galectin-glycan interactions.Galectin-1 inhibitors and their potential therapeutic applications: a patent review.Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes.Site-Specific N-Glycosylation of Endothelial Cell Receptor Tyrosine Kinase VEGFR-2.Central Role of Metabolism in Endothelial Cell Function and Vascular Disease.Possible role of sialylation of retinal protein glycans in the regulation of electroretinogram response in mice.Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis.Retinal and choroidal angiogenesis: a review of new targets.Fucosylated Antigens in Cancer: An Alliance toward Tumor Progression, Metastasis, and Resistance to Chemotherapy.Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic Therapies.Clinical relevance of galectin-1 in hematologic malignancies treated with non-myeloablative hemopoietic stem cell transplantation.
P2860
Q26752363-BF6340F9-3CE2-4E88-8026-5598DFDFE2CEQ28068654-1FD19E5D-5B2A-49F1-B004-2B426F648FD9Q33779141-8D61C174-DBBA-4ADE-9101-05D2E39D4D0CQ35076790-D523D50E-08F5-40FC-B949-BA8BBA7D30AEQ38583449-FA7057EC-2F35-4CAA-A602-402FFCE6C013Q38763827-8DDB08B0-E582-4F80-9E4D-DDA67878EAC7Q39012279-CF59144F-818A-4FD2-9B15-130841133010Q39102302-36AF377E-E5B6-4725-85C6-133299663ADBQ39137289-DB85A75A-9DB1-4E67-A0BB-9A3F253F0C62Q41374149-E14ABAC8-F37E-4193-9052-199BB8CA9713Q47983641-D8C58BB1-6565-4244-9828-7249AFF01789Q53098522-D962A7F2-CC66-4FB8-AE49-3FBEE462091DQ53703015-ACB6C5E9-7B87-42BC-A5F2-2E924508E46DQ53743967-14E6E333-325B-462A-8647-12CE537E3F7CQ54085734-FB6D9C16-A6DD-4515-91AC-E26B74FF2A82
P2860
Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Regulatory role of glycans in ...... y to anti-angiogenic treatment
@ast
Regulatory role of glycans in ...... y to anti-angiogenic treatment
@en
Regulatory role of glycans in ...... y to anti-angiogenic treatment
@nl
type
label
Regulatory role of glycans in ...... y to anti-angiogenic treatment
@ast
Regulatory role of glycans in ...... y to anti-angiogenic treatment
@en
Regulatory role of glycans in ...... y to anti-angiogenic treatment
@nl
prefLabel
Regulatory role of glycans in ...... y to anti-angiogenic treatment
@ast
Regulatory role of glycans in ...... y to anti-angiogenic treatment
@en
Regulatory role of glycans in ...... y to anti-angiogenic treatment
@nl
P2093
P2860
P3181
P356
P1433
P1476
Regulatory role of glycans in ...... y to anti-angiogenic treatment
@en
P2093
Diego O Croci
Gabriel A Rabinovich
Juan P Cerliani
Nicolas A Pinto
P2860
P304
P3181
P356
10.1093/GLYCOB/CWU083
P407
P577
2014-12-01T00:00:00Z